CALC
NASDAQCalciMedica Inc.
Price$1.13-2.37 (-67.70%)
2026-07-162026-10-16
News · 26 weeks56+63%
2026-04-192026-10-11
Mix3790d
- Insider18(49%)
- SEC Filings12(32%)
- Other6(16%)
- Analyst1(3%)
Latest news
25 items- SECSEC Form 8-K filed by CalciMedica Inc.8-K - CalciMedica, Inc. (0001534133) (Filer)
- INSIDERSEC Form 4 filed by CalciMedica Inc.4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by CalciMedica Inc.4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by CalciMedica Inc.4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by CalciMedica Inc.4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by CalciMedica Inc.4 - CalciMedica, Inc. (0001534133) (Issuer)
- SECSEC Form 8-K filed by CalciMedica Inc.8-K - CalciMedica, Inc. (0001534133) (Filer)
- SECSEC Form 424B5 filed by CalciMedica Inc.424B5 - CalciMedica, Inc. (0001534133) (Filer)
- INSIDERSEC Form 4 filed by Chief Medical Officer Hebbar Sudarshan4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by Chief Scientific Officer Stauderman Kenneth A.4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Bardin Stephen4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by CHIEF EXECUTIVE OFFICER Leheny A. Rachel4 - CalciMedica, Inc. (0001534133) (Issuer)
- SECSEC Form S-8 filed by CalciMedica Inc.S-8 - CalciMedica, Inc. (0001534133) (Filer)
- SECSEC Form 8-K filed by CalciMedica Inc.8-K - CalciMedica, Inc. (0001534133) (Filer)
- PRCalciMedica to Participate in the H.C. Wainwright 28th Annual Global Investment ConferenceLA JOLLA, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- CalciMedica, Inc. ("CalciMedica" or the "Company") (NASDAQ:CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious inflammatory, immunologic, and cardiopulmonary diseases, today announced that Management will present and participate in 1x1 investor meetings at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026. About CalciMedicaCalciMedica is a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious inflammatory, immunolog
- SECSEC Form 8-K filed by CalciMedica Inc.8-K - CalciMedica, Inc. (0001534133) (Filer)
- SECSEC Form 8-K filed by CalciMedica Inc.8-K - CalciMedica, Inc. (0001534133) (Filer)
- PRCalciMedica Announces One-for-Five Reverse Stock SplitLA JOLLA, Calif., Aug. 27, 2026 (GLOBE NEWSWIRE) -- CalciMedica Inc. ("CalciMedica" or the "Company") (NASDAQ:CALC), a clinical-stage biopharmaceutical company developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for serious inflammatory, immunologic, and cardiopulmonary diseases, today announced that it will effect a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-5, effective at 5:00 p.m. ET on August 28, 2026. CalciMedica’s common stock will begin trading on the Nasdaq Capital Market on a split-adjusted basis commencing upon market open on August 31, 2026 under CalciMedica’s existing trading symbol "CALC" with a new
- SECSEC Form SCHEDULE 13G filed by CalciMedica Inc.SCHEDULE 13G - CalciMedica, Inc. (0001534133) (Subject)
- INSIDERSEC Form 4 filed by Large owner Alafi Capital Co Llc4 - CalciMedica, Inc. (0001534133) (Issuer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by CalciMedica Inc.SCHEDULE 13D/A - CalciMedica, Inc. (0001534133) (Subject)
- INSIDERSEC Form 4 filed by Director Shaw Allan4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by Director Glicklich Alan4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by Director Guerard Frederic4 - CalciMedica, Inc. (0001534133) (Issuer)
- INSIDERSEC Form 4 filed by Director Zaytsev Evgeny4 - CalciMedica, Inc. (0001534133) (Issuer)
CALC FAQ
6 questionsWhere does CALC stock trade?
CalciMedica Inc. (CALC) is listed on NASDAQ.What sector and industry is CALC in?
CalciMedica Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did CalciMedica Inc. go public?
CalciMedica Inc. (CALC) completed its IPO in 2023.What are analysts saying about CALC?
CalciMedica Inc. has had 2 recent analyst actions on file. The most recent action was from Guggenheim: Buy with a $900.00 price target on 2026-08-20. Recent price targets cluster around $900.00.What companies are similar to CALC?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.), NVS (Novartis AG). Compare CALC side-by-side with any of them on Quantisnow.How can I track CALC on Quantisnow?
Quantisnow aggregates CalciMedica Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CALC to receive live email and push alerts on every new disclosure.